BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2549303)

  • 1. Mineralocorticoid specificity of renal type I receptors: binding and metabolism of corticosterone.
    Doyle D; Smith R; Krozowski ZS; Funder JW
    J Steroid Biochem; 1989 Aug; 33(2):165-70. PubMed ID: 2549303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equivalent affinity of aldosterone and corticosterone for type I receptors in kidney and hippocampus: direct binding studies.
    Sheppard KE; Funder JW
    J Steroid Biochem; 1987 Dec; 28(6):737-42. PubMed ID: 2826920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity.
    Krozowski ZS; Funder JW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6056-60. PubMed ID: 6310613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone.
    Beaumont K; Fanestil DD
    Endocrinology; 1983 Dec; 113(6):2043-51. PubMed ID: 6227474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid specificity of renal type I receptors: in vivo binding studies.
    Sheppard K; Funder JW
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E224-9. PubMed ID: 3030124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of steroids to mineralocorticoid receptors: implications for in vivo occupancy by glucocorticoids.
    Lan NC; Graham B; Bartter FC; Baxter JD
    J Clin Endocrinol Metab; 1982 Feb; 54(2):332-42. PubMed ID: 6274900
    [No Abstract]   [Full Text] [Related]  

  • 8. Receptor binding and biological activity of 18-oxocortisol.
    Gomez-Sanchez CE; Gomez-Sanchez EP; Smith JS; Ferris MW; Foecking MF
    Endocrinology; 1985 Jan; 116(1):6-10. PubMed ID: 2856875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors.
    Funder JW; Pearce PT; Smith R; Campbell J
    Endocrinology; 1989 Oct; 125(4):2224-6. PubMed ID: 2551643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RU-26988--a new tool for the study of the mineralocorticoid receptor.
    Gomez-Sanchez CE; Gomez-Sanchez EP
    Endocrinology; 1983 Sep; 113(3):1004-9. PubMed ID: 6307658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I receptors in parotid, colon, and pituitary are aldosterone selective in vivo.
    Sheppard K; Funder JW
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E467-71. PubMed ID: 2821824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system.
    Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP
    Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extravascular CBG-like sites in rat kidney and mineralocorticoid receptor specificity.
    Stephenson G; Krozowski Z; Funder JW
    Am J Physiol; 1984 Feb; 246(2 Pt 2):F227-33. PubMed ID: 6320679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of aldosterone receptors in rat kidney: effects of steroid treatment and potassium diet.
    Rafestin-Oblin ME; Claire M; Lombes M; Michaud A; Corvol P
    J Steroid Biochem; 1984 Oct; 21(4):465-70. PubMed ID: 6238210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid receptors in human kidney.
    Matulich DT; Spindler BJ; Schambelan M; Baxter JD
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1170-4. PubMed ID: 993320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralocorticoid receptors in vitro and the antialdosterone activity in vivo.
    Wambach G; Casals-Stenzel J
    Biochem Pharmacol; 1983 May; 32(9):1479-85. PubMed ID: 6222738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortisol 17 beta acid, transcortin, and the heterogeneity of rat brain glucocorticoid receptors.
    Sheppard KE; Funder JW
    J Steroid Biochem; 1986 Aug; 25(2):285-8. PubMed ID: 3747528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary.
    Reul JM; de Kloet ER; van Sluijs FJ; Rijnberk A; Rothuizen J
    Endocrinology; 1990 Aug; 127(2):907-15. PubMed ID: 2164924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of steroid receptors in the gut and kidney of the frog (Rana catesbeiana) and in the gut of the turtle (Chrysemys picta).
    Mehi AZ; DiBattista JA; Sandor T
    J Steroid Biochem; 1987 May; 26(5):627-39. PubMed ID: 3035288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid binding to cardiac type I receptors: in vivo studies.
    Pearce PT; Funder JW
    J Hypertens Suppl; 1988 Dec; 6(4):S131-3. PubMed ID: 3241188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.